Growth hormone increases mRNA levels of PPARδ and foxo 1 in skeletal muscle of growth hormone deficient lit/lit mice

Endocrine Journal

Volumn 56, Issue 1, 2009, Pages 141-147

  Kim, Dong Sun ^a,b,d,e   Itoh, Emina ^a   Iida, Keiji ^c   Thorner, Michael O ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b Hanyang University   (South Korea)

^c Department of Internal Medicine   (Japan)

^d Hanyang University Hospital ^*

^e Hanyang University College of Medicine   (South Korea)

Author keywords

Foxo 1; Growth hormone; PPAR delta; Skeletal muscle

Indexed keywords

ACYL COENZYME A OXIDASE; GROWTH HORMONE; INSULIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; SOMATOMEDIN C; TRANSCRIPTION FACTOR FKHR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; ENERGY METABOLISM; FATTY ACID METABOLISM; INSULIN BLOOD LEVEL; LIPOLYSIS; MALE; MOUSE; MUSCLE METABOLISM; NONHUMAN; TRANSCRIPTION REGULATION;

ACYL-COA OXIDASE; ANIMALS; BODY WEIGHT; DWARFISM, PITUITARY; FORKHEAD TRANSCRIPTION FACTORS; GROWTH HORMONE; HOMOZYGOTE; INSULIN; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUSCLE, SKELETAL; PPAR ALPHA; PPAR DELTA; RNA, MESSENGER; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; UP-REGULATION;

EID: 62549104904     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K08E-219     Document Type: Article

References (34)

1. Leung KC, Ho KYY (1997) Stimulation of Mitochondrial Fatty Acid Oxidation by Growth Hormone in Human Fibroblasts. J Clin Endocrinol Metab 82: 4208-4213.
2. Hioki C, Yoshida T, Kogure A, Takakura Y, Umekawa T, Yoshioka K, Shimatsu A, Yoshikawa T (2004) Effects of growth hormone (GH) on mRNA levels of uncoupling proteins 1, 2, and 3 in brown and white adipose tissues and skeletal muscle in obese mice. Horm Metab Res 36: 607-613.
3. Amri FZ, Bonino G, Ailhaud NA, Abumrad P, Grimaldi A (1995) Cloning of a protein that mediates transcriptional effects of fatty acids in preadipocytes. Homology to peroxisome proliferator-activated receptors. J Biol Chem 270: 2367-2371.
4. Hertz R, Berman I, Keppler D, Bar-Tana J (1996) Activation of gene transcription by prostacyclin analogues is mediated by the peroxisome- proliferator-activated receptor (PPAR). Eur J Biochem 235: 242-247.
5. Shaw N, Elholm M, Noy N (2003) Retinoic acid is a high affinity selective ligand for the peroxisome proliferator-activated receptor β/δ. J Biol Chem 278: 41589-41592.
6. Muoio DM, MacLean PS, Lang DB, Li S, Houmand JA, Way JM, Winegar DA, Corton JC, Dohm GL, Kraus WE (2002) Fatty acid homeostasis and induction of lipid regulatory genes in skeletal muscles of peroxisome proliferator-activated receptor (PPAR) a knockout mice. Evidence for compensatory regulation by PPAR5. J Biol Chem 277: 26089-26097.
7. Luquet S, Lopez-Soriano J, Holst D, Fredenrich A, Melki J, Rassoulzadegan M, Grimaldi PA (2003) Peroxisome proliferator-activated receptor δ controls muscle development and oxidative capability. FASEB J 17: 2299-2301.
8. Schoonjans K, Martin G, Staels B, Auwerex J (1997) Peroxisome proliferator-activated receptors, orphans with ligands and functions. Curr Opin Lipidol 8: 159-166.
9. Reddy JK, Hashimoto T (2001) Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system. Annu Rev Nutr 21: 193-230.
10. Farmer SR (2003) The forkhead transcription factor Foxo 1: a possible link between obesity and insulin resistance. Mol Cell 11: 6-8.
11. Stitt TN, Drujan D, Clarke BA, Panaro F, Timofeyva Y, Kline WO, Gonzalez M, Yancopoulos GD, Glass DJ (2004) The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell 14: 395-403.
12. Furuyama T, Kitayama K, Yamashita H, Mori N (2003) Forkhead transcription factor FOXO l (FKHR)- dependent induction of PDK4 gene expression in skeletal muscle during energy deprivation. Biochem J 375: 365-371.
13. Bastie CC, Nahle Z, McLoughlin T, Esser K, Zhang W, Unterman T, Abumrad NA (2005) FoxO l stimulates fatty acid uptake and oxidation in muscle cells through CD36-dependent and-independent mechanisms. J Biol Chem 280: 14222-14229.
14. Huang B, Wu P, Bowker-Kinley MM, Harris RA (2002) Regulation of pyruvate dehydrogenase kinase expression by peroxisome proliferator-activated receptor-a ligands, glucocorticoids, and insulin. Diabetes 51: 276-283.
15. Cheng TC, Beamer WG, Phillips JA, Bartke A, Mallonee RL, Dowling C (1983) Etiology of growth hormone deficiency in little, Ames and Snell dwarf mice. Endocrinology 133: 1669-1678.
16. Godfrey P, Rahal JO, Beamer WG, Copeland NG, Jenkins NA, Mayo KE (1993) GHRH receptor of little mice contains a missense mutation in the extracellular domain that disrupts receptor function. Nat Genet 4: 227-232.
17. Freedlender AE, Vandenhoff GE, Macleod MS, Malcolm RR (1984) Radioimmunoassay of Insulin. In: Methods in Diabetes Research. Wiley Interscience, New York: 296.
18. Rozen S, Skaletsky H (2000) Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 132: 365-386.
19. Imae M, Fu Z, Yoshida A, Noguchi T, Kato H (2003) Nutritional and hormonal factors control the gene expression of FoxOs, the mammalian homologues of DAF-16. J Mol Endocrinol 30: 253-262.
20. Zhou YC, Davey HW, McLachlan MJ, Xie T, Waxman DJ (2002) Elevated basal expression of liver peroxisomal β-oxidation enzymes and CYP4A microsomal fatty acid ω-hydroxylase in STAT5b(-/-) mice: crosstalk in vivo between peroxisome proliferator-activated receptor and signal transducer and activator of transcription signaling pathways. Toxicol Appl Pharmacol 182: 1-10.
21. Donahue LR, Beamer WG (1993) Growth hormone deficiency in 'little' mice results in aberrant body composition, reduced insulin-like growth factor-I and insulin-like growth factor-binding protein-3 (IGFBP-3), but does not affect IGFBP-2,-1 or-4. J Endocrinol 136: 91-104.
22. Itoh E, Iida K, del Rincon JP, Kim DS, Thorner MO (2004) Diurnal variation in growth hormone receptor messenger ribonucleic acid in liver and skeletal muscle of lit/+ and lit/lit mice. Endoer J51: 529-535.
23. Weigle DS, Selfridge LE, Schwartz MW, Seeley RJ, Cummings DE, Havel PJ, Kuijper KL, BeltrandelRio H (1998) Elevated free fatty acids induce uncoupling protein 3 expression in muscle: a potential explanation for the effect of fasting. Diabetes 47: 298-302.
24. Cortright RN, Zheng D, Jones JP, Fluckey JD, Dicarlo SE, Grujic D, Lowell BB, Dohm GL (1999) Regulation of skeletal muscle UCP-2 and UCP-3 gene expression by exercise and denervation. Am J Physiol 276: E217- E221.
25. Berry SA, Yoon J-B, List J, Seelig S (1993) Hepatic fatty acid-binding protein mRNA is regulated by growth hormone. J Am Coll Nutr 12: 638-642.
26. Willi SM, Zhang Y, Key Jr LL, Kelly DP (1995) Growth hormone stimulates the expression of enzymes in hepatic fatty acid metabolism. Proc of the 77th Annual Meeting of The Endocrine Society, p 347 (Abstract).
27. Leone TC, Weinheimer CJ, Kelly DP (1999) A critical role for the peroxisome proliferator-activated receptor a (PPARa) in the cellular fasting response: the PPARa-null mouse as a model of fatty acid oxidation disorders. Proc Natl Acad Sci USA 22: 7473-7478.
28. Muoio DM, Way JM, Tanner CJ, Winegar DA, Kliewer SA, Houmard JA, Kraus WE, Dohm GL (2002) Peroxisome proliferator-activated receptor-a regulates fatty acid utilization in primary human skeletal muscle cells. Diabetes 51: 901-909.
29. Hoffman EP, Nader GA (2004) Balancing muscle hypertrophy and atrophy. Nat Med 10: 584-585.
30. Leger B, Cartoni R, Praz M, Lamon S, Deriaz O, Crettenand A, Gobelet C, Rohmer P, Konzelmann M, Luthi F, Russell AP (2006) Akt signalling through GSK-3 beta mTOR and FoxO l is involved in human skeletal muscle hypertrophy and atrophy. J Physiol 576: 923-933.
31. Wang X, Hu Z, Du Hu J, Mitch WE (2006) Insulin resistance accelerates muscle protein degradation: Activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling. Endocrinology 147: 4160-4168.
32. Motojima K, Seto K (2003) Fibrates and statins rapidly and synergistically induce pyruvate dehydrogenase kinase 4 mRNA in the liver and muscles of mice. Biol Pharm Bull 26: 954-958.
33. Abbot EL, McCormack JG, Reynet C, Hassall DG, Buchan KW, Yeaman SJ (2005) Diverging regulation of pyruvate dehydrogenase kinase isoform gene expression in cultured human muscle cells. FEBS J 272: 3004-3014.
34. Constantin D, Constantin-Teodosiu D, Layfield R, Tsintzas K, Bennett AJ, Greenhaff PL (2007) PPAR-delta agonism induces a change in fuel metabolism and activation of an atrophy programme, but does not impair mitochondrial function in rat skeletal muscle. J Physiol 15: 381-390.